An attempt to regrow the infamous GFAJ-1 bacteria, reported to incorporate arsenic into its DNA backbone, has failed.
Advertisement
The Scientist
Most Recent
Our list of the best and brightest products that 2011 had to offer the life scientist
A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times
A list of this year’s newsworthy successes—and failures—in drug development
Researchers have mapped out the DNA of what some scientists claim to be an arsenic loving bacterium.
New research suggests that a controversial class of stem cells originates in the heart and retains some ability to repair damaged tissue.
The pharmaceutical darling that has brought billions in revenue to Pfizer over the past 15 years will now share the shelves with its generic competitors.
A special glucose molecule makes tumor cells more vulnerable to a pair of cancer cell-killing drugs.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
